CompletedNot Applicable

Dexmedetomidine as an Intrathecal Adjuvant to Hyperbaric Bupivacaine for Postoperative Analgesia in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction Surgeries

Egypt64 participantsStarted 2023-09-01

Plain-language summary

This study aimed to evaluate the effect of adding low doses of dexmedetomidine to hyperbaric bupivacaine during spinal anesthesia on post operative analgesia characteristics in Arthroscopic Anterior Cruciate Ligament Reconstruction Surgeries

Who can participate

Age range21 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged from 21 to 50 years. * Both genders. * American society of anesthesiologists (ASA) physical status I and II. * Patients scheduled for arthroscopic anterior cruciate ligament reconstruction surgeries under spinal anesthesia. Exclusion Criteria: * Patient refusal. * Body Mass Index (BMI) more than 40 kg/m2. * Patients who were taking analgesics for chronic pain on opioid therapy or have a history of drug abuse. * Uncooperative patient. * Patients with coagulation disorders. * History of local anesthetics allergy. * Infection at the needle puncture site. * Patients with significant respiratory, cardiac, renal or hepatic disorders

What they're measuring

Total morphine consumption

Timeframe: 24 hours postoperatively

Trial details

NCT IDNCT06667024

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Dexmedetomidine trials